(Q33940919)

30 July 2017

title

Comprehensive analysis of cellular galectin-3 reveals no consistent oncogenic function in pancreatic cancer cells (English)

1 reference

30 July 2017

1 reference

Thomas M Gress

4

0 references

author name string

Alexander Hann

1

1 reference

30 July 2017

Anja Gruner

2

1 reference

30 July 2017

Ying Chen

3

1 reference

30 July 2017

Malte Buchholz

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

16 June 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

6

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

e20859

1 reference

Creative Commons Attribution 4.0 International

30 July 2017

copyright license

start time

16 June 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

5 July 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Galectin-3 expression is associated with bladder cancer progression and clinical outcome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Clinical significance of Galectin-3 in clear cell renal cell carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Regulation of prostate cancer progression by galectin-3

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Pancreatic stellate cells promote proliferation and invasiveness of human pancreatic cancer cells via galectin-3

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Galectin-3: an open-ended story

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Galectins as modulators of tumour progression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

New pancreas cancers cell lines that represent distinct stages of ductal differentiation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Correlation between spontaneous metastatic potential and type I collagenolytic activity in a human pancreatic cancer cell line (SUIT-2) and sublines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020859

Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020859

Inverse Modulation of Steady-State Messenger RNA Levels of Two Non-Integrin Laminin-Binding Proteins in Human Colon Carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0020859

SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116838

Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma

29 October 2018

1 reference

12 December 2020

Galectin-3 expression in human breast carcinoma: correlation with cancer histologic grade

1 reference

12 December 2020

Decreased expression of galectin-3 is associated with progression of human breast cancer

1 reference

12 December 2020

Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas

1 reference

12 December 2020

Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas

1 reference

12 December 2020

Expression of Galectin-3 in renal neoplasms: a diagnostic, possible prognostic marker

1 reference

12 December 2020

Decreased galectin-3 expression during the progression of cervical neoplasia

1 reference

12 December 2020

Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissue

1 reference

12 December 2020

Localization of galectin-3 in normal and diseased pancreatic tissue

1 reference

12 December 2020

Involvement of galectin-3 expression in colorectal cancer progression and metastasis

1 reference

12 December 2020

Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma

1 reference

12 December 2020

Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer

1 reference

12 December 2020

Expression of a 31-kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas

1 reference

12 December 2020

Increased galectin-3 expression in gastric cancer: correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation

1 reference

12 December 2020

Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer

1 reference

12 December 2020

Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions

1 reference

12 December 2020

Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties

1 reference

12 December 2020

Differential expression of galectin 3 and galectin 1 in colorectal cancer progression

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0020859

Identifiers

DOI

1 reference

30 July 2017

0 references

1 reference

30 July 2017

1 reference